Publisher: Medscape


The Bad News Behind the Rise in Locum Tenens

In the Media Icon

I’ve worked locum tenens off and on since 1982. Flexible schedules allowed me to write several books, pursue a parallel career as a medical journalist, lead medical missions in the Philippines, and develop modest expertise as an underwater photographer. But the recent rise in locum tenens practitioners signals trouble for medicine.


Coinfection Fails to Affect Babesia Outcomes

In the Media Icon

“Cases of human babesiosis are increasing in the United States, and this study helped to characterize the mortality risk of babesiosis along with tick-borne co-infections,” said Shirin Mazumder, MD, associate professor and infectious disease specialist at the University of Tennessee Health Science Center, Memphis, Tennessee, in an interview.


Secrets of a Neurology Whisperer: Talk Less, Teach More

In the Media Icon

A recent medical scare reminded me of an ancient teaching axiom: “What you do is more important than what you say.” As an associate professor of neurology, my primary responsibility is to educate medical students and neurology residents. In addition to the occasional didactic lecture, teaching takes place at the hospital and clinic in the… Read More


Balancing Risks: Colonoscopy in Older Patients With Dementia

In the Media Icon

“Colonoscopy screening is vital for colorectal cancer prevention in older adults, significantly reducing mortality by detecting precancerous polyps and early-stage cancers. However, the adoption of such screening in dementia patients is understudied,” said Minghui Sam Li, PhD, assistant professor of clinical pharmacy and translational sciences at the University of Tennessee Health Science Center, Memphis, Tennessee.


New Era? ‘Double Selective’ Antibiotic Spares the Microbiome

In the Media Icon

A new antibiotic uses a never-before-seen mechanism to deliver a direct hit on tough-to-treat infections while leaving beneficial microbes alone.


New Brain Death Criteria: Reaching Consensus

In the Media Icon

I’m Dr Andrew Wilner. Today, I have the pleasure of speaking with Dr Lucas Elijovich. Lucas is a colleague of mine, and he’s also a specialist in critical care and director of neurocritical care at University of Tennessee Health Science Center (UTHSC), where we both work.


SGLT2 Inhibitors for Diabetes Safe, Effective in Older Adults

In the Media Icon

Sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes appear to be as safe and effective in people aged 65 years and older as in younger individuals, new research suggests. Findings from a real-world observational study of 50 older adults with type 2 diabetes were recently presented here at the International… Read More


RSV: Investigational Drug Shows Promise in Challenge Study

In the Media Icon

John P. DeVincenzo, MD, from the University of Tennessee College of Medicine and the Children’s Foundation Research Institute at Le Bonheur Children’s Hospital, Memphis, Tennessee, and colleagues published their findings in the November 19 issue of the New England Journal of Medicine.